NG-Nitroarginine Methyl Ester
"NG-Nitroarginine Methyl Ester" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A non-selective inhibitor of nitric oxide synthase. It has been used experimentally to induce hypertension.
| Descriptor ID |
D019331
|
| MeSH Number(s) |
D12.125.068.050.525 D12.125.095.104.525
|
| Concept/Terms |
NG-Nitroarginine Methyl Ester- NG-Nitroarginine Methyl Ester
- Methyl Ester, NG-Nitroarginine
- NG Nitroarginine Methyl Ester
- N omega-Nitro-L-arginine Methyl Ester
- N omega Nitro L arginine Methyl Ester
- NG-Nitro-L-Arginine Methyl Ester
- Methyl Ester, NG-Nitro-L-Arginine
- NG Nitro L Arginine Methyl Ester
- N(G)-Nitroarginine Methyl Ester
- N(omega)-Nitro-L-arginine Methyl Ester
- L-NAME
- N(G)-Nitro-L-arginine Methyl Ester
|
Below are MeSH descriptors whose meaning is more general than "NG-Nitroarginine Methyl Ester".
Below are MeSH descriptors whose meaning is more specific than "NG-Nitroarginine Methyl Ester".
This graph shows the total number of publications written about "NG-Nitroarginine Methyl Ester" by people in this website by year, and whether "NG-Nitroarginine Methyl Ester" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1996 | 0 | 1 | 1 |
| 1997 | 0 | 2 | 2 |
| 1999 | 0 | 2 | 2 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 2 | 2 |
| 2004 | 0 | 2 | 2 |
| 2006 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
| 2017 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "NG-Nitroarginine Methyl Ester" by people in Profiles.
-
Nitric oxide production by glomerular podocytes. Nitric Oxide. 2018 01 30; 72:24-31.
-
Chronic Hypertension Leads to Neurodegeneration in the TgSwDI Mouse Model of Alzheimer's Disease. Hypertension. 2015 Jul; 66(1):175-82.
-
Tyrosine nitration of prostacyclin synthase is associated with enhanced retinal cell apoptosis in diabetes. Am J Pathol. 2011 Dec; 179(6):2835-44.
-
Prostacyclin and milrinone by aerosolization improve pulmonary hemodynamics in newborn lambs with experimental pulmonary hypertension. J Appl Physiol (1985). 2010 Sep; 109(3):677-84.
-
Blockade of renal medullary bradykinin B2 receptors increases tubular sodium reabsorption in rats fed a normal-salt diet. Am J Physiol Renal Physiol. 2008 Sep; 295(3):F811-7.
-
Nitric oxide mediates cardiac protection of tissue kallikrein by reducing inflammation and ventricular remodeling after myocardial ischemia/reperfusion. Life Sci. 2008 Jan 16; 82(3-4):156-65.
-
Microvascular versus macrovascular dysfunction in type 2 diabetes: differences in contractile responses to endothelin-1. Exp Biol Med (Maywood). 2006 Jun; 231(6):1016-21.
-
Manganese potentiates in vitro production of proinflammatory cytokines and nitric oxide by microglia through a nuclear factor kappa B-dependent mechanism. Toxicol Sci. 2005 Mar; 84(1):139-48.
-
Astrocytic nitric oxide triggers tau hyperphosphorylation in hippocampal neurons. In Vivo. 2004 May-Jun; 18(3):275-80.
-
Important role of nitric oxide in the effect of angiotensin-converting enzyme inhibitor imidapril on vascular injury. Hypertension. 2003 Oct; 42(4):542-7.